Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 7
Submit an article Journal homepage
255
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Prognostic value of lactate dehydrogenase in Chinese patients with newly diagnosed transplant eligible multiple myeloma

Beihui HuangDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;
,
Jin LuDepartment of Hematology, Peking University Institute of Hematology, Peking University People’s Hospital, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China;
,
Xiaotao WangDepartment of Hematology, Guilin Medical College, Guilin, China;
,
Yang XiaoDepartment of Hematology, The General Hospital of Guangzhou Military Command of PLA, Guangzhou, China;
,
Ying ZhaoDepartment of Hematology, The First People’s Hospital of Foshan, Foshan, China;
,
Hongming HuangDepartment of Hematology, Affiliated Hospital of Nantong University, Nantong, China
,
Junru LiuDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;
,
Meilan ChenDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;
,
Jingli GuDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;
,
Shiwen YuanDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;
,
Dong ZhengDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;
,
Yonghua LiDepartment of Hematology, The General Hospital of Guangzhou Military Command of PLA, Guangzhou, China;
,
Xiaojun HuangDepartment of Hematology, Peking University Institute of Hematology, Peking University People’s Hospital, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2145-6643
ORCID Icon &
Juan LiDepartment of Hematology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Correspondence[email protected]
 show all
Pages 1740-1742 | Received 13 Mar 2016, Accepted 18 Oct 2016, Published online: 23 Nov 2016

References

  • Terpos E, Katodritou E, Roussou M, et al. High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents. Eur J Haematol. 2010;85:114–119.
  • Papanikolaou X, Repousis P, Tzenou T, et al. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Leuk Lymphoma. 2013;54:1459–1464.
  • Abdallah AO, Atrash S, Shahid Z, et al. Patterns of central nervous system involvement in relapsed and refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2014;14:211–214.
  • Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for Multiple Myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33:2863–2869.
  • Barlogie B, Anaissie E, van Rhee F, et al. Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3. Br J Haematol. 2007;138:176–185.
  • Chim CS, Sim J, Tam S, et al. LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens. Eur J Haematol. 2015;94:330–335.
  • Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia. 2006;20:1467–1473.
  • Gkotzamanidou M, Kastritis E, Gavriatopoulou MR, et al. Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk. 2011;11:409–413.
  • Park S, Han B, Kim K, et al. Renal insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement. Anticancer Res. 2014;34:4299–4306.
  • Shaughnessy J Jr, Tian E, Sawyer J, et al. Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II. Br J Haematol. 2003;120:44–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.